Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
Pending
verification pending
Revenue YoY
—
reported change
EBITDA
Pending
latest reported figure
Source
bse pending
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
SBI Life reported a strong Q1 FY25 with PAT up 36% YoY to INR 5.2B, driven by robust new business premium growth of 13% to INR 70.3B and improved operational efficiency (OpEx ratio down 70bps to 6.1%). VNB grew 12% to INR 9.7B, though VNB margin contracted to 26.8% due to lower protection sales and temporary yield absorption. Agency channel outperformed with 48% APE growth, while bancassurance grew 12% with expected acceleration in H2. Management guided for high-teens to 20% APE growth and margins around ±28% for FY25. Key risks include slower-than-expected recovery in protection business and potential margin impact from new surrender value norms, though management expects minimal effect.
Colored figures show movement against the previous available record.
Guidance to track
- Management reiterated guidance for APE growth in the high-teens to 20% range for the full year, driven by bancassurance recovery and agency momentum.
- Management expects VNB margin to remain in the range of ±28% for the full year, with product mix improvement compensating for Q1 margin decline.
- A simplified protection product with three-click issuance will be launched on SBI's YONO platform in Q2 FY25, targeting higher sales.
- A high-sum-assured protection product for the ultra HNI segment will be launched in August 2024, with simplified underwriting.
Risks flagged
- Protection new business premium declined, impacting VNB margins. Management acknowledged the blip and is launching new products to revive growth.
- Regulatory changes to surrender value may compress margins. Management expects minimal impact (<1%) but did not quantify precisely.
- Bancassurance grew only 12% in Q1, and achieving full-year guidance relies on acceleration in H2, which may not materialize if seasonality disappoints.
- Increased competition from other insurers in tier 2/3 cities could pressure market share, though management downplayed the impact.
Key quotes
- We stand by the guidance that we gave during the end of the last financial year results. Our top line growth will be in high teens-20%. Regarding the margin also, we will be in the same range of ±28% kind of...
- SBI Life being the lowest cost operator, and also because of the kind of product mix that we have at SBI Life, we will be the least affected company.
- Our mis-selling ratio stands at just 0.04%, which is lowest in the industry.
Research modules